Merlin drug
Evidence from:
primary |
all sources
Related entities (7)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| Beagle | interacts_with | Merlin | — | 1 |
| genotyping error | risk_factor_for | Merlin | — | 1 |
| HAPI-UR | interacts_with | Merlin | — | 1 |
| Merlin | interacts_with | SHAPEIT2 | — | 1 |
| Merlin | associated_with | simulated data | — | 1 |
| Merlin | interacts_with | SNP | — | 1 |
| SHAPEIT2 | interacts_with | Merlin | — | 1 |
Mentioned in (5)
Papers in which this entity is mentioned.
- Genetic linkage analysis in the age of whole-genome sequencing. (2015)
- A general approach for haplotype phasing across the full spectrum of relatedness. (2014)
- Dosage transmission disequilibrium test (dTDT) for linkage and association detection. (2013)
- Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. (2012)
- Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes? (2009)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| merlin | drug | 5 | 11 |
| merlin version 0.10.1 | drug | — | — |